rs4986918
Positions:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1
The NM_000795.4(DRD2):c.132C>T(p.Leu44=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00343 in 1,614,256 control chromosomes in the GnomAD database, including 162 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.019 ( 85 hom., cov: 33)
Exomes 𝑓: 0.0018 ( 77 hom. )
Consequence
DRD2
NM_000795.4 synonymous
NM_000795.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.59
Genes affected
DRD2 (HGNC:3023): (dopamine receptor D2) This gene encodes the D2 subtype of the dopamine receptor. This G-protein coupled receptor inhibits adenylyl cyclase activity. A missense mutation in this gene causes myoclonus dystonia; other mutations have been associated with schizophrenia. Alternative splicing of this gene results in two transcript variants encoding different isoforms. A third variant has been described, but it has not been determined whether this form is normal or due to aberrant splicing. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.46).
BP6
Variant 11-113424520-G-A is Benign according to our data. Variant chr11-113424520-G-A is described in ClinVar as [Benign]. Clinvar id is 416374.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.59 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0636 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DRD2 | NM_000795.4 | c.132C>T | p.Leu44= | synonymous_variant | 2/8 | ENST00000362072.8 | NP_000786.1 | |
DRD2 | NM_016574.4 | c.132C>T | p.Leu44= | synonymous_variant | 2/7 | NP_057658.2 | ||
DRD2 | XM_017017296.3 | c.132C>T | p.Leu44= | synonymous_variant | 2/8 | XP_016872785.1 | ||
DRD2 | XM_047426511.1 | c.132C>T | p.Leu44= | synonymous_variant | 2/7 | XP_047282467.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DRD2 | ENST00000362072.8 | c.132C>T | p.Leu44= | synonymous_variant | 2/8 | 1 | NM_000795.4 | ENSP00000354859 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0187 AC: 2854AN: 152246Hom.: 84 Cov.: 33
GnomAD3 genomes
AF:
AC:
2854
AN:
152246
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00482 AC: 1211AN: 251454Hom.: 34 AF XY: 0.00344 AC XY: 468AN XY: 135912
GnomAD3 exomes
AF:
AC:
1211
AN:
251454
Hom.:
AF XY:
AC XY:
468
AN XY:
135912
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00184 AC: 2686AN: 1461892Hom.: 77 Cov.: 31 AF XY: 0.00159 AC XY: 1157AN XY: 727246
GnomAD4 exome
AF:
AC:
2686
AN:
1461892
Hom.:
Cov.:
31
AF XY:
AC XY:
1157
AN XY:
727246
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0187 AC: 2856AN: 152364Hom.: 85 Cov.: 33 AF XY: 0.0178 AC XY: 1329AN XY: 74514
GnomAD4 genome
AF:
AC:
2856
AN:
152364
Hom.:
Cov.:
33
AF XY:
AC XY:
1329
AN XY:
74514
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
11
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 09, 2021 | - - |
Dystonic disorder Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 22, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at